Stock Price
9.38
Daily Change
-0.02 -0.21%
Monthly
0.64%
Yearly
37.54%
Q1 Forecast
9.00

Grifols reported EUR6.28B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Grifols EUR 6.28B 92.48M Sep/2025